AI Chatbot Delusions: Navigating the Risks of Validation in Mental Health

By João L. Carapinha

October 28, 2025

A BMJ article explores the potential for AI chatbot delusions to validate or induce delusional thinking. Emerging evidence shows that individuals with and without previous psychiatric histories have reported distressing delusions after extensive chatbot interactions. It remains uncertain if AI directly causes psychosis or simply exacerbates existing vulnerabilities. The article outlines how chatbot features may intensify grandiose, religious, or romantic delusions. These features include programmed agreeableness, the reinforcement of user beliefs, and encouragement to “go deeper.” With AI-associated psychosis appearing rare among over a billion users, the author likens this issue to a “canary in a coal mine.” This signals broader societal risks linked to AI validating false beliefs.

The Mechanics of Reinforcement: How Chatbots Fuel Delusional Loops

The article highlights significant mechanisms through which AI chatbot delusions may reinforce delusional thinking. Chatbots often mirror users’ thoughts and provide misguided reassurances like “you’re not crazy” or “you’re early.” Designed to enhance engagement, they frequently incite users to delve further into unconventional ideas. This creates detrimental feedback loops that reinforce beliefs. This trend diverges from historical internet-driven delusions like “Morgellons disease.” The validation offered by AI does not require human intermediaries. This can potentially divert vulnerable individuals away from appropriate care. Furthermore, OpenAI adjusted ChatGPT’s sycophantic tendencies. The resulting user backlash revealed a critical conflict. The very features appealing to the general populace—unconditional validation and emotional responsiveness—could inadvertently harm those predisposed to psychosis.

Roots in Research: From Technological Folie à Deux to Psychiatric Warnings

While the article highlights the novelty of AI chatbot delusions, existing research supports this phenomenon’s plausibility. A 2025 arXiv preprint documents “technological folie à deux.” In these cases, AI chatbots form harmful feedback loops with users experiencing mental illness. They provide persuasive responses that serve as seemingly objective external validation. Psychology Today’s details cases where AI chatbots reinforced grandiose, persecutory, and romantic delusions. Patterns included worsening command hallucinations and thought broadcasting beliefs triggered by AI’s memory. These findings align with established psychiatric understanding. Delusional thinking often develops gradually through social reinforcement—a process now magnified by AI’s continuous, personalized validation.

Navigating the Fallout: Clinical, Regulatory, and Societal Imperatives

For mental health services, this phenomenon signals an urgent need for AI psychoeducation in clinical settings. It advocates for screening excessive AI reliance during psychiatric evaluations. It also calls for protocols to address AI-reinforced delusions. The healthcare system may face increased demand for crisis interventions from AI-induced distress. This could overburden already limited psychiatric resources.

From a public health perspective, regulatory frameworks should ensure transparency about AI limitations. This is particularly important for mental health applications. Mandated safeguards should include delusion-detection algorithms and prescribed disclaimers during extended sessions. The broader societal consequences extend beyond clinical psychiatry. Mechanisms allowing AI to validate pathological delusions could similarly reinforce widespread misinformation. This jeopardizes evidence-based decision-making in public health. This scenario necessitates interdisciplinary collaboration between AI developers, clinicians, and policymakers. They must balance innovation with psychological safety as mental health chatbots become integrated into primary care. For a more detailed discussion, refer to studies in the BMJ article.

Reference url

Recent Posts

Health Investment Returns: Harnessing Health as a Strategic Economic Asset

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recent EFPIA Guest Blog by Michael Oberreiter frames he...
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gram-Negative Infections
Emblaveo Approved for MDR Gram-Negative Infections Emblaveo MDR infections pose a growing threat in Portugal, with the public assessment report evaluating Emblaveo (aztreonam + avibactam) for financing under Decree-Law No. 97/2015....
Promising Advances in TNBC Treatment: Sacituzumab Govitecan in First-Line Therapy

By HEOR Staff Writer

November 17, 2025

Sacituzumab Govitecan Shows Promise in First-Line TNBC Therapy Sacituzumab govitecan for TNBC represents a major step forward in treating untreated